Sex Steroids and Major Psychoses: Which Role for DHEA-S and Progesterone

Massimiliano Buoli, Alice Caldiroli, Marta Serati, Silvia Grassi, A. Carlo Altamura

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective: Endocrine pathways seem to play a role in the etiology of major psychoses. The identification of biomarkers associated with psychotic symptoms in schizophrenia (SKZ) and mood disorders would allow the identification of high-risk subjects for delusions and hallucinations. The aim of this study was to evaluate dehydroepiandrosterone sulfate (DHEA-S) and progesterone plasma levels in drug-free patients with major psychoses and their relation with the diagnosis and history of psychotic symptoms. Methods: Eighty-nine consecutive drug-free male inpatients with SKZ or mood disorders were recruited, and DHEA-S and progesterone plasma levels were measured. The groups, divided according to pathological/normal-range hormone levels, were compared in terms of clinical variables using χ2 tests with Bonferroni's corrections or multivariate analyses of variance. The same analyses were performed for groups divided according to the presence/absence of lifetime psychotic symptoms. Binary logistic regression analysis was performed using hormone levels as independent variables and history of lifetime psychotic symptoms as a dependent one. Results: A higher number of patients with abnormal DHEA-S levels was found to have a family history of major depressive disorder (p <0.05). Higher DHEA-S levels (F = 8.31; p = 0.005) were found in patients with a history of psychotic symptoms. In addition, binary logistic regression confirmed that DHEA-S levels were associated with a higher probability of lifetime psychotic symptoms (p = 0.037). Conclusions: Our results confirm previous data about the role of endocrine factors in the etiology of major psychoses. A high DHEA-S level might be a risk factor for psychotic symptoms. Studies with larger samples are needed to confirm these data.

Original languageEnglish
Pages (from-to)178-183
Number of pages6
JournalNeuropsychobiology
Volume73
Issue number3
DOIs
Publication statusPublished - 2016

Fingerprint

Dehydroepiandrosterone Sulfate
Psychotic Disorders
Progesterone
Steroids
Mood Disorders
Logistic Models
Hormones
Delusions
Hallucinations
Major Depressive Disorder
Pharmaceutical Preparations
Inpatients
Schizophrenia
Analysis of Variance
Reference Values
Multivariate Analysis
Biomarkers
Regression Analysis

Keywords

  • Dehydroepiandrosterone sulfate
  • Major psychoses
  • Neuroendocrine biomarkers#
  • Progesterone

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuropsychology and Physiological Psychology
  • Biological Psychiatry

Cite this

Sex Steroids and Major Psychoses : Which Role for DHEA-S and Progesterone. / Buoli, Massimiliano; Caldiroli, Alice; Serati, Marta; Grassi, Silvia; Altamura, A. Carlo.

In: Neuropsychobiology, Vol. 73, No. 3, 2016, p. 178-183.

Research output: Contribution to journalArticle

Buoli, Massimiliano ; Caldiroli, Alice ; Serati, Marta ; Grassi, Silvia ; Altamura, A. Carlo. / Sex Steroids and Major Psychoses : Which Role for DHEA-S and Progesterone. In: Neuropsychobiology. 2016 ; Vol. 73, No. 3. pp. 178-183.
@article{47ba48d7f715412097154d0290c6afd7,
title = "Sex Steroids and Major Psychoses: Which Role for DHEA-S and Progesterone",
abstract = "Objective: Endocrine pathways seem to play a role in the etiology of major psychoses. The identification of biomarkers associated with psychotic symptoms in schizophrenia (SKZ) and mood disorders would allow the identification of high-risk subjects for delusions and hallucinations. The aim of this study was to evaluate dehydroepiandrosterone sulfate (DHEA-S) and progesterone plasma levels in drug-free patients with major psychoses and their relation with the diagnosis and history of psychotic symptoms. Methods: Eighty-nine consecutive drug-free male inpatients with SKZ or mood disorders were recruited, and DHEA-S and progesterone plasma levels were measured. The groups, divided according to pathological/normal-range hormone levels, were compared in terms of clinical variables using χ2 tests with Bonferroni's corrections or multivariate analyses of variance. The same analyses were performed for groups divided according to the presence/absence of lifetime psychotic symptoms. Binary logistic regression analysis was performed using hormone levels as independent variables and history of lifetime psychotic symptoms as a dependent one. Results: A higher number of patients with abnormal DHEA-S levels was found to have a family history of major depressive disorder (p <0.05). Higher DHEA-S levels (F = 8.31; p = 0.005) were found in patients with a history of psychotic symptoms. In addition, binary logistic regression confirmed that DHEA-S levels were associated with a higher probability of lifetime psychotic symptoms (p = 0.037). Conclusions: Our results confirm previous data about the role of endocrine factors in the etiology of major psychoses. A high DHEA-S level might be a risk factor for psychotic symptoms. Studies with larger samples are needed to confirm these data.",
keywords = "Dehydroepiandrosterone sulfate, Major psychoses, Neuroendocrine biomarkers#, Progesterone",
author = "Massimiliano Buoli and Alice Caldiroli and Marta Serati and Silvia Grassi and Altamura, {A. Carlo}",
year = "2016",
doi = "10.1159/000444922",
language = "English",
volume = "73",
pages = "178--183",
journal = "Neuropsychobiology",
issn = "0302-282X",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Sex Steroids and Major Psychoses

T2 - Which Role for DHEA-S and Progesterone

AU - Buoli, Massimiliano

AU - Caldiroli, Alice

AU - Serati, Marta

AU - Grassi, Silvia

AU - Altamura, A. Carlo

PY - 2016

Y1 - 2016

N2 - Objective: Endocrine pathways seem to play a role in the etiology of major psychoses. The identification of biomarkers associated with psychotic symptoms in schizophrenia (SKZ) and mood disorders would allow the identification of high-risk subjects for delusions and hallucinations. The aim of this study was to evaluate dehydroepiandrosterone sulfate (DHEA-S) and progesterone plasma levels in drug-free patients with major psychoses and their relation with the diagnosis and history of psychotic symptoms. Methods: Eighty-nine consecutive drug-free male inpatients with SKZ or mood disorders were recruited, and DHEA-S and progesterone plasma levels were measured. The groups, divided according to pathological/normal-range hormone levels, were compared in terms of clinical variables using χ2 tests with Bonferroni's corrections or multivariate analyses of variance. The same analyses were performed for groups divided according to the presence/absence of lifetime psychotic symptoms. Binary logistic regression analysis was performed using hormone levels as independent variables and history of lifetime psychotic symptoms as a dependent one. Results: A higher number of patients with abnormal DHEA-S levels was found to have a family history of major depressive disorder (p <0.05). Higher DHEA-S levels (F = 8.31; p = 0.005) were found in patients with a history of psychotic symptoms. In addition, binary logistic regression confirmed that DHEA-S levels were associated with a higher probability of lifetime psychotic symptoms (p = 0.037). Conclusions: Our results confirm previous data about the role of endocrine factors in the etiology of major psychoses. A high DHEA-S level might be a risk factor for psychotic symptoms. Studies with larger samples are needed to confirm these data.

AB - Objective: Endocrine pathways seem to play a role in the etiology of major psychoses. The identification of biomarkers associated with psychotic symptoms in schizophrenia (SKZ) and mood disorders would allow the identification of high-risk subjects for delusions and hallucinations. The aim of this study was to evaluate dehydroepiandrosterone sulfate (DHEA-S) and progesterone plasma levels in drug-free patients with major psychoses and their relation with the diagnosis and history of psychotic symptoms. Methods: Eighty-nine consecutive drug-free male inpatients with SKZ or mood disorders were recruited, and DHEA-S and progesterone plasma levels were measured. The groups, divided according to pathological/normal-range hormone levels, were compared in terms of clinical variables using χ2 tests with Bonferroni's corrections or multivariate analyses of variance. The same analyses were performed for groups divided according to the presence/absence of lifetime psychotic symptoms. Binary logistic regression analysis was performed using hormone levels as independent variables and history of lifetime psychotic symptoms as a dependent one. Results: A higher number of patients with abnormal DHEA-S levels was found to have a family history of major depressive disorder (p <0.05). Higher DHEA-S levels (F = 8.31; p = 0.005) were found in patients with a history of psychotic symptoms. In addition, binary logistic regression confirmed that DHEA-S levels were associated with a higher probability of lifetime psychotic symptoms (p = 0.037). Conclusions: Our results confirm previous data about the role of endocrine factors in the etiology of major psychoses. A high DHEA-S level might be a risk factor for psychotic symptoms. Studies with larger samples are needed to confirm these data.

KW - Dehydroepiandrosterone sulfate

KW - Major psychoses

KW - Neuroendocrine biomarkers#

KW - Progesterone

UR - http://www.scopus.com/inward/record.url?scp=84964292737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964292737&partnerID=8YFLogxK

U2 - 10.1159/000444922

DO - 10.1159/000444922

M3 - Article

AN - SCOPUS:84964292737

VL - 73

SP - 178

EP - 183

JO - Neuropsychobiology

JF - Neuropsychobiology

SN - 0302-282X

IS - 3

ER -